Fungicidal activity of miconazole against Candida spp. biofilms

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 4, 2010, Pages 694-700

  Vandenbosch, Davy ^a   Braeckmans, Kevin ^a   Nelis, Hans J ^a   Coenye, Tom ^a  

^a GHENT UNIVERSITY   (Belgium)

Author keywords

Apoptosis; Ascorbic acid; Reactive oxygen species

Indexed keywords

ANNEXIN; ANTIOXIDANT; ASCORBIC ACID; CERIVASTATIN; FLUCONAZOLE; MICONAZOLE; REACTIVE OXYGEN METABOLITE; ANTIFUNGAL AGENT;

ANTIFUNGAL SUSCEPTIBILITY; APOPTOSIS; ARTICLE; BIOFILM; CANDIDA; CANDIDA ALBICANS; FUNGAL STRAIN; FUNGICIDAL ACTIVITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLANKTON; PLATE COUNT; SESSILE SPECIES; BACTERIAL COUNT; DRUG EFFECT; HUMAN; METABOLISM; MICROBIAL VIABILITY; MICROBIOLOGICAL EXAMINATION;

ANNEXINS; ANTIFUNGAL AGENTS; APOPTOSIS; BIOFILMS; CANDIDA; COLONY COUNT, MICROBIAL; HUMANS; MICONAZOLE; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; REACTIVE OXYGEN SPECIES;

EID: 77952575700     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq019     Document Type: Article

References (22)

1. Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol 2003; 11: 30-6.
2. Kojic EM, Darouiche RO. Candida infections of medical devices. Clin Microbiol Rev 2004; 17: 255-67.
3. Chandra J, Kuhn DM, Mukherjee PK et al. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 2001; 183: 5385-94.
4. Hawser SP, Douglas LJ. Resistance of Candida albicans biofilms to antifungal agents in vitro. Antimicrob Agents Chemother 1995; 39: 2128-31.
5. Yoshida Y. Cytochrome P450 of fungi: primary target for azole antifungal agents. Curr Top Med Mycol 1988; 2: 388-418.
6. Kobayashi D, Kondo K, Uehara N et al. Endogenous reactive oxygen species is an important mediator of miconazole antifungal effect. Antimicrob Agents Chemother 2002; 46: 3113-7.
7. François IEJA, Cammue BPA, Borgers M et al. Azoles: mode of antifungal action and resistance development. Effect of miconazole on endogenous reactive oxygen species production in Candida albicans. Curr Med Chem 2006; 5: 1-11.
8. Thevissen K, Ayscough KR, Aerts AM et al. Miconazole induces changes in actin cytoskeleton prior to reactive oxygen species induction in yeast. J Biol Chem 2007; 282: 21592-7.
9. Lamfon H, Porter SR, McCullough M et al. Susceptibility of Candida albicans biofilms grown in a constant depth film fermentor to chlorhexidine, fluconazole and miconazole: a longitudinal study. J Antimicrob Chemother 2004; 53: 383-5.
10. Ortega GR, Delgado JN. Vitamins and related compounds. In: Delgado JN, Remers WA, eds. Textbook of Organic Medicinal and Pharmaceutical Chemistry. New York: Lippincott-Raven, 1998; 888-90.
11. Madeo F, Engelhardt S, Herker E et al. Apoptosis in yeast: a new model system with applications in cell biology and medicine. Curr Genet 2002; 41: 208-16.
12. Madeo F, Fröhlich E, Ligr M et al. Oxygen stress: a regulator of apoptosis in yeast. J Cell Biol 1999; 145: 757-67.
13. Madeo F, Herker E, Wissing S et al. Apoptosis in yeast. Curr Opin Microbiol 2004; 7: 655-60.
14. Gourlay CW, Ayscough KR. Actin-induced hyperactivation of the RAS signaling pathway leads to apoptosis in Saccharomyces cerevisiae. Mol Cell Biol 2006; 26: 6487-501.
15. Phillips AJ, Sudbery I, Ramsdale M. Apoptosis induced by environmental stresses and amphotericin B in Candida albicans. Proc Natl Acad Sci USA 2003; 100: 14327-32.
16. Peeters E, Nelis HJ, Coenye T. Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J Microbiol Meth 2008; 72: 157-65.
17. TM, a novel disinfecting formula for the maintenance of oral medical devices. J Appl Microbiol 2008; 105: 733-40.
18. Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST). Method for the determination of minimum inhibitory concentration (MIC) by broth dilution of fermentative yeasts. Clin Microbiol Infect 2003; 9: i-viii.
19. Schinabeck MK, Long LA, Hossain MA et al. Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy. Antimicrob Agents Chemother 2004; 48: 1727-32.
20. Buckler BS, Sams RN, Goei VL et al. Treatment of central venous catheter fungal infection using liposomal amphotericin-B lock therapy. Pediatr Infect Dis J 2008; 27: 762-4.
21. Seneviratne CJ, Wang Y, Jin L et al. Candida albicans biofilm formation is associated with increased anti-oxidative capacities. Proteomics 2008; 8: 2936-47.
22. Gourlay CW, Carpp LN, Timpson P et al. A role for the actin cytoskeleton in cell death and aging in yeast. J Cell Biol 2004; 164: 803-9.